Zobrazeno 1 - 10
of 29
pro vyhledávání: '"Shinsuke, Ogusu"'
Autor:
Chiho Nakashima, Yuki Kuwahara, Syo Kitamura, Keita Kai, Masafumi Hiratsuka, Kokoro Kajiwara, Natsuko Komiya, Shinsuke Ogusu, Shinya Kimura, Naoko Sueoka-Aragane
Publikováno v:
Current Problems in Cancer: Case Reports, Vol 14, Iss , Pp 100298- (2024)
Immune checkpoint inhibitors (ICIs) are indispensable agents that may improve the long-term prognosis of non-small cell lung cancer. However, clinicians should always be aware that its immune-modulating mechanism of action may lead to unexpected immu
Externí odkaz:
https://doaj.org/article/6940523685644382b242120e76a6812a
Autor:
Ayu Kiritani, Yoshiaki Amino, Ken Uchibori, Takahiro Akita, Yuhei Harutani, Shinsuke Ogusu, Ryosuke Tsugitomi, Ryo Manabe, Ryo Ariyasu, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 15, Iss 5, Pp 402-409 (2024)
Abstract Background As an epidermal growth factor receptor‐tyrosine kinase inhibitor (EGFR‐TKI), osimertinib has emerged as a standard EGFR‐mutation positive treatment for non‐small cell lung cancer (NSCLC). However, the efficacy of osimertin
Externí odkaz:
https://doaj.org/article/bf9f4e65fe294138b6c32c0d9d62d1af
Autor:
Yuki Kurihara, Hiroki Tashiro, Koichiro Takahashi, Ryo Tajiri, Yuki Kuwahara, Kokoro Kajiwara, Natsuko Komiya, Shinsuke Ogusu, Chiho Nakashima, Tomomi Nakamura, Shinya Kimura, Naoko Sueoka‐Aragane
Publikováno v:
Thoracic Cancer, Vol 13, Iss 24, Pp 3459-3466 (2022)
Abstract Background Transbronchial biopsy (TBB) with endobronchial ultrasonography and a guide sheath (EBUS‐GS) is an effective examination tool for the diagnosis of lung cancer. Factors related to making the diagnosis are still not fully understoo
Externí odkaz:
https://doaj.org/article/38204ae12a7642fdbc2c3fb279351a4d
Clinical influence of switching companion diagnostic tests for EGFR‐TKs from Therascreen to Cobas v2
Autor:
Ken Uchibori, Natsuki Takano, Ryo Manabe, Ryosuke Tsugitomi, Shinsuke Ogusu, Takehiro Tozuka, Hiroaki Sakamoto, Hiroshi Yoshida, Yoshiaki Amino, Ryo Ariyasu, Satoru Kitazono, Noriko Yanagitani, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 12, Iss 6, Pp 906-913 (2021)
Abstract Background Several companion diagnostic (CDx) tests for epidermal growth factor receptor tyrosine kinase inhibitors (EGFR‐TKIs) have been approved. In our institute, the CDx test for EGFR‐TKIs was changed from the Therascreen test (Thera
Externí odkaz:
https://doaj.org/article/59e40e267c2d484f9b71094fb6334be9
Feasibility of next‐generation sequencing test for patients with advanced NSCLC in clinical practice
Autor:
Ryo Ariyasu, Ken Uchibori, Hironori Ninomiya, Shinsuke Ogusu, Ryosuke Tsugitomi, Ryo Manabe, Hiroaki Sakamaoto, Takehiro Tozuka, Hiroshi Yoshida, Yoshiaki Amino, Satoru Kitazono, Noriko Yanagitani, Kengo Takeuchi, Makoto Nishio
Publikováno v:
Thoracic Cancer, Vol 12, Iss 4, Pp 504-511 (2021)
Abstract Background The usefulness of the Oncomine Dx Target test (Oncomine Dx), a next‐generation sequencing (NGS) test, has already been proven in clinical trials. However, NGS requires high‐quality tumor samples and takes a long time to genera
Externí odkaz:
https://doaj.org/article/7b7ef5a8795d4eb2b4b8ec0478f05a2a
Autor:
Hiroaki Sakamoto, Noriko Yanagitani, Ryo Manabe, Ryosuke Tsugitomi, Shinsuke Ogusu, Takehiro Tozuka, Hiroshi Yoshida, Yoshiaki Amino, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Sadatomo Tasaka, Makoto Nishio
Publikováno v:
Cancer Reports, Vol 4, Iss 6, Pp n/a-n/a (2021)
Abstract Background Most patients treated with anaplastic lymphoma kinase (ALK)‐tyrosine kinase inhibitors for ALK‐positive non‐small cell lung cancer (NSCLC) develop resistance, leading to metastasis, with progression to the central nervous sy
Externí odkaz:
https://doaj.org/article/e37385b3c00c43baa5109687ecafc390
Autor:
Kazutoshi Komiya, Tomomi Nakamura, Tomonori Abe, Shinsuke Ogusu, Chiho Nakashima, Koichiro Takahashi, Shinya Kimura, Naoko Sueoka‐Aragane
Publikováno v:
Thoracic Cancer, Vol 10, Iss 9, Pp 1798-1804 (2019)
Background Immune‐related adverse events (irAEs) should be anticipated with treatment by immune checkpoint inhibitors (ICIs). Although the relationship between irAEs and efficacy of ICI has been reported, it has not yet been clarified whether the b
Externí odkaz:
https://doaj.org/article/9044d244544c42ff8113deebf3293ee8
Paraneoplastic Limbic Encephalitis Complicated with Small Cell Lung Cancer at the Time of Recurrence
Autor:
Hironori Sadamatsu, Yuki Kurihara, Koichiro Takahashi, Kazutoshi Komiya, Shinsuke Ogusu, Haruki Hirakawa, Hiroki Tashiro, Chiho Nakashima, Tomomi Nakamura, Naoko Sueoka-Aragane
Publikováno v:
Case Reports in Oncology, Vol 12, Iss 2, Pp 466-472 (2019)
Paraneoplastic limbic encephalitis (PLE) is a rare neurologic disorder that can complicate various malignancies, including lung cancer. PLE is most frequently found the initial presentation of lung cancer. In this study, we reported the case of a 74-
Externí odkaz:
https://doaj.org/article/0135a00d27fb4e22a91d0c9f83ae8557
Autor:
Masahide Tanaka, Koichiro Takahashi, Yuki Kurihara, Mihoko Yamamoto-Rikitake, Shinsuke Ogusu, Haruki Hirakawa, Hironori Sadamatsu, Kazutoshi Komiya, Tomomi Nakamura, Naoko Sueoka-Aragane
Publikováno v:
Case Reports in Oncology, Vol 11, Iss 2, Pp 412-417 (2018)
Pulmonary tumor thrombotic microangiopathy (PTTM) is a rare disease that shows hypoxia with severe pulmonary hypertension related to malignant tumor. Diagnosis is difficult due to rapid clinical progression and the need to demonstrate pathological fi
Externí odkaz:
https://doaj.org/article/1a2e377eec3c4a359fc472d7492a5612
Autor:
Takehiro Tozuka, Noriko Yanagitani, Hiroshi Yoshida, Ryo Manabe, Shinsuke Ogusu, Ryosuke Tsugitomi, Hiroaki Sakamoto, Yoshiaki Amino, Ryo Ariyasu, Ken Uchibori, Satoru Kitazono, Masahiro Seike, Akihiko Gemma, Makoto Nishio
Publikováno v:
Investigational New Drugs.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::97a654b36bc107428b3b561f7291cc5d
https://doi.org/10.1007/s10637-023-01358-3
https://doi.org/10.1007/s10637-023-01358-3